Elvira Velasco en la Comisión de Sanidad y Consumo

The GPP Health spokesperson proposes that the Spanish Medicines Agency make recommendations on the necessary protective material in future pandemics, on the path of the English Agency

Remember that Spain was the country with the most infected health professionals in the world, which had to do "with the protection material that our professionals needed and did not arrive" as a result of "chaos" in its distribution

"The purchasing center assumed by the Government did not work and they had to rectify to allow the Autonomous Communities to restore their purchases," he stresses.

He is grateful for the work done by the pharmaceutical industry, distribution and the Pharmacy offices themselves during the state of alarm so that "no Spaniard was missing any medicine"

Regrets that the appearance of the director of the Spanish Agency for Medicines and Health Products (AEMPS) in the Health Commission did not occur "during the entire alarm process"

She is interested before the director of the AEMPS in whether clinical trials are included in the Spanish registry of clinical studies, in the strategic reserve of drugs for future pandemics and in the cut of 8,000 million in drugs.

Source of new